LLY vs WST
By Alex · Tickerpine
Eli Lilly and Company vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | WST |
|---|---|---|
| Price | $1,443.50 | $416.42 |
| Market cap | $1.29T | $29.01B |
| P/E ratio | 46.9 | 46.7 |
| ROE | 86.02% | 21.23% |
| Profit margin | 31.90% | 18.81% |
| Revenue growth | 38.60% | 8.70% |
| Dividend yield | 0.48% | 0.25% |
| Beta | 0.39 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs WST in plain English
- LLY is the bigger company — about 44.3× the market cap of WST.
- WST is cheaper on earnings (P/E 46.7 vs 46.9).
- LLY earns a higher return on equity (86% vs 21%).
- LLY is growing revenue faster (39% vs 9%).
- LLY has the higher dividend yield (0.48% vs 0.25%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.